Ann Lab Med.  2016 Jul;36(4):393-395. 10.3343/alm.2016.36.4.393.

Possible Transfusion-Related Acute Lung Injury Following Convalescent Plasma Transfusion in a Patient With Middle East Respiratory Syndrome

Affiliations
  • 1Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. duck.cho@skku.edu
  • 2Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • 3Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. krpeck@skku.edu
  • 4Department of Laboratory Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.

Abstract

No abstract available.


MeSH Terms

Acute Lung Injury/*etiology
Adult
Blood Transfusion/*adverse effects
Coronavirus/genetics/isolation & purification
Coronavirus Infections/*diagnosis/virology
Humans
Male
Oximetry
Real-Time Polymerase Chain Reaction
Republic of Korea
Viral Proteins/genetics/metabolism
Viral Proteins

Figure

  • Fig. 1 Clinical and laboratory features of the patient before and after transfusion-related acute lung injury. (A) PaO2/FiO2 ratio, (B) oxygen saturation (pulse oximetry) and partial pressure of oxygen (PaO2) and carbon dioxide (PaCO2) of arterial blood, (C) pH and bicarbonate (HCO3-) of arterial blood, (D) white blood cell count and lactate dehydrogenase (LDH) levels.Abbreviation: FiO2, fraction of inspired oxygen.


Reference

1. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV)-Republic of Korea. Updated on Oct 2015. http://www.who.int/csr/don/25-october-2015-mers-korea/en/.
2. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015; 386:995–1007. PMID: 26049252.
Article
3. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015; 211:80–90. PMID: 25030060.
Article
4. MacLennan S, Barbara JA. Risks and side effects of therapy with plasma and plasma fractions. Best Pract Res Clin Haematol. 2006; 19:169–189. PMID: 16377549.
Article
5. Schmickl CN, Mastrobuoni S, Filippidis FT, Shah S, Radic J, Murad MH, et al. Male-predominant plasma transfusion strategy for preventing transfusion-related acute lung injury: a systematic review. Crit Care Med. 2015; 43:205–225. PMID: 25514705.
6. Mora-Rillo M, Arsuaga M, Ramírez-Olivencia G, de la Calle F, Borobia AM, Sánchez-Seco P, et al. Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain. Lancet Respir Med. 2015; 3:554–562. PMID: 26041403.
Article
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr